Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,218.00
(
1.73%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
98.47
(
1.80%
)
Bitcoin
78,352.03
(
0.15%
)
News Focus
News Focus

Replies to post #129218 on Biotech Values

Replies to #129218 on Biotech Values
icon url

DewDiligence

12/06/11 6:37 PM

#132552 RE: ghmm #129218

FDA removes the most burdensome feature of Nplate REMS:

http://finance.yahoo.com/news/Amgen-FDA-Agree-Modify-Nplate-prnews-99459556.html?x=0
icon url

ghmm

01/26/12 5:02 PM

#135850 RE: ghmm #129218

Nplate Sales:

Sales of Nplate® (romiplostim) increased 23 percent to $80 million in the fourth quarter of 2011 versus $65 million in the fourth quarter of 2010.

http://wwwext.amgen.com/media/media_pr_detail.jsp?releaseID=1653300